Sort
23,748 grants matching “melanoma”
Targeting UHRF1 in combinational immunotherapy
$468,277Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
Mechanisms of cell death in cutaneous melanoma
$468,265Andrew E Aplin · Thomas Jefferson University · R01 · FY2023 · CA
0-glycoprotein podoplanin in vascular development
$468,220Rodger Paul McEver · Oklahoma Medical Research Foundation · P01 · FY2012 · HL
Training Program in Cancer Immunobiology
$468,198Bradley W McIntyre · University Of Tx Md Anderson Can Ctr · T32 · FY2009 · CA
Targeting UHRF1 in combinational immunotherapy
$468,148Xiao-Fan Wang · Duke University · R01 · FY2020 · CA
SOUTHWEST ONCOLOGY GROUP
$468,138Swedish Medical Center, First Hill · U10 · FY2003 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$468,091Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
$468,091Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$468,055Antoni Ribas · California Institute Of Technology · P01 · FY2011 · CA
INFLAMMATORY CELL DEATH IN UVEAL MELANOMA
$468,000Thomas Jefferson University · · FY2021 · Defense Health Agency
TARGETING THE INTERACTION OF G BETA-GAMMA AND MUTANT G ALPHA Q/11 IN UVEAL MELANOMA
$468,000Thomas Jefferson University · · FY2021 · Defense Health Agency
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$467,825James K Turkson · University Of Hawaii At Manoa · R01 · FY2014 · CA
Melanoma RAS/BRAF Mutation: Heterogeneity-Risk-Prognosis
$467,820Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2013 · CA
Chronic Mitochondrial Division and Melanoma: Mechanism, Prognosis, and Therapy
$467,789Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$467,757Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$467,757Chuan-Yuan Li · Duke University · R01 · FY2020 · CA
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$467,624Antoni Ribas · California Institute Of Technology · P01 · FY2012 · CA
B cells in autoimmunity following checkpoint blockade therapy
$467,621Kavita Dhodapkar · Emory University · R01 · FY2019 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$467,591Haifa Shen · Methodist Hospital Research Institute · R01 · FY2018 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$467,536Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects
$467,405John B Sunwoo · Stanford University · R01 · FY2022 · DE
Molecular Epidemiology of Melanoma
$467,302University Of Pennsylvania · R01 · FY2002 · CA
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system
$467,188Anna Karolina Palucka · Jackson Laboratory · R01 · FY2015 · CA
The Nodal Signaling Pathway In Embryonic Development
$467,080Michael Kuehn · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
NMR of Melanoma Acidification, Bioenergetics, Metabolism and Therapeutic Response
$466,922Jerry D Glickson · University Of Pennsylvania · R01 · FY2010 · CA